Table 2.
Demographic and clinical characteristics of the participants in the acute COVID-19 and post-COVID-19 period.
| Group | n (%) | n (%) |
|---|---|---|
| Acute COVID-19 | Severe (n = 44) | Nonsevere (n = 43) |
| Sex | ||
| Male | 25 (56.82) | 23 (53.49) |
| Female | 19 (43.18) | 20 (46.51) |
| Age | ||
| 21–40 | 6 (13.63) | 13 (30.23) |
| 41–60 | 21 (47.73) | 23 (53.49) |
| > 60 | 17 (38.64) | 7 (16.28) |
| Comorbidities | ||
| Present | 22 (50) | 14 (32.56) |
| Absent | 22 (50) | 29 (67.44) |
| Post-COVID | Long COVID (n = 30) | No long COVID (n = 31) |
|---|---|---|
| Sex | ||
| Male | 10 (33.33) | 16 (51.61) |
| Female | 20 (66.67) | 15 (48.39) |
| Age | ||
| 18–39 | 9 (30.00) | 18 (58.06) |
| 40–60 | 20 (66.67) | 13 (41.94) |
| > 60 | 1 (3.33) | 0 (0.00) |
| Comorbidities | ||
| Present | 11 (36.67) | 5 (16.13) |
| Absent | 19 (63.33) | 26 (83.87) |
| Symptoms | ||
| Dyspnea, muscle weakness, chest pain, tremor, fatigue, myalgia, headache, insomnia, visual changes, lower limb edema | 30 (100) | 0 (0.00) |
n: number of individuals; comorbidities: diabetes mellitus, chronic cardiovascular disease, obesity, chronic kidney disease, lower limb edema.